drugset / Trial / NCT03055936

Dose-finding Pharmacokinetic Study in Healthy Males

NCT03055936

Phase 1 Completed 56 enrolled Orion Corporation, Orion Pharma
RandomizedCrossoverOpen-labelTreatment

Summary

This is a phase I PK study in healthy males.

Timeline

Start
2017-02-21
Primary completion
2017-06-09
Completion
2017-06-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Carbidopa Unknown 12.5 mg
Subject Carbidopa Unknown 25 mg
Subject Carbidopa Unknown 65 mg
Subject Levodopa Small molecule 50 mg
Subject Levodopa Small molecule 100 mg
Subject Levodopa Small molecule 150 mg
Subject ODM-104 Unknown 50 mg
Subject ODM-104 Unknown 100 mg

Indications

No indication recorded.